Ophthalmic zoster treated with cytosine arabinoside
Peterlejtner, E.
Klinika Oczna 48(2): 71-72
1978
ISSN/ISBN: 0023-2157 PMID: 306475 Document Number: 126229
Document emailed within 1 workday
Related Documents
Goudsmit, R. 1972: Cytosine arabinoside in the treatment of severe herpes zoster and varicella Nederlands Tijdschrift Voor Geneeskunde 116(5): 200Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Nowacki, P.; Dolińska, D.; Honczarenko, K.; Zyluk, B. 1992: Atrophy of the granular layer of the cerebellar cortex in patients with nonlymphoblastic leukemia treated with cytosine arabinoside Neurologia i Neurochirurgia Polska 26(4): 482-489
Colbert, N.; Najman, A.; Gorin, N.C.; Blum, F.; Treisser, A.; Lasfargues, G.; Cloup, M.; Barrat, H.; Duhamel, G. 1980: Acute leukaemia during pregnancy: favourable course of pregnancy in two patients treated with cytosine arabinoside and anthracyclines La Nouvelle Presse Medicale 9(3): 175-178
Cetkovský, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis Vnitrni Lekarstvi 40(11): 730-734
Kufe, D.W.; Spriggs, D.R. 1985: Biochemical and cellular pharmacology of cytosine arabinoside Seminars in Oncology 12(2 Suppl 3: 34-48
Pytel-Dabrowska, T.; Balcar-Boroń, A.; Nowaczyk-Michalak, A. 1980: Cytosine arabinoside in the treatment of herpes simplex and chickenpox Wiadomosci Lekarskie 33(12): 957-959
Gallo, J.H.; Rozenberg, M.C. 1986: Response of refractory anemia to low-dose cytosine arabinoside Australian and New Zealand Journal of Medicine 16(2): 231-233
Hanka, L.J.; Kuentzel, S.L.; Neil, G.L. 1970: Improved microbiological assay for cytosine arabinoside (NSC-63878) Cancer ChemoTherapy Reports 54(6): 393-397
Madon, E.; Baroncelli, P.G.; Sacerdote, A.; Roberi, P.L. 1971: Treatment of acute leukemias in the infancy with cytosine arabinoside Minerva Pediatrica 23(26): 1125-1129
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Tatsumi, N.; Masaoka, T.; Ueda, Y.; Senda, N. 1970: Treatment of leukemia with cytosine arabinoside--on the intensification of remission Gan no Rinsho. Japan Journal of Cancer Clinics 16(7): 706-712
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Yang, G.S.; Minden, M.D.; McCulloch, E.A. 1993: Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside Leukemia 7(7): 1012-1019
Rose, W.C.; Trader, M.W.; Laster, W.R.; Schabel, F.M. 1978: Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide Cancer Treatment Reports 62(9): 1337-1349
Morrison, P.F.; Lincoln, T.L.; Aroesty, J. 1975: Disposition of cytosine arabinoside (NSC-63878) and its metabolites: a pharmacokinetic simulation Cancer ChemoTherapy Reports 59(4): 861-876
Kreis, W.; Woodcock, T.M.; Gordon, C.S.; Krakoff, I.H. 1977: Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man Cancer Treatment Reports 61(7): 1347-1353
Wdzieczak-Bakala, J.; Guigon, M.; Lenfant, M.; Frindel, E. 1983: Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment Biomedicine and PharmacoTherapy 37(9-10): 467-471